US Broker Ratings

Solventum Corporation (SOLV) Stock Analysis: Exploring a 12% Upside Potential and Robust ROE

Investors seeking opportunities in the healthcare sector should take a closer look at Solventum Corporation (NYSE: SOLV), a company making strides in medical instruments and supplies. With a market capitalization..

Takeda Pharmaceutical Company L (TAK) Stock Analysis: 11.97% Upside Potential Amid Strong Buy Ratings

Takeda Pharmaceutical Company Limited (NYSE: TAK) stands as a noteworthy player in the global pharmaceutical industry, with a robust portfolio spanning gastroenterology, rare diseases, oncology, and more. Headquartered in Tokyo,..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Assessing a Potential 18% Upside in the Medical Device Sector

Investors looking for opportunities in the healthcare sector might want to take a closer look at Zimmer Biomet Holdings, Inc. (NYSE: ZBH), a prominent player in the medical devices industry..

Intuitive Surgical, Inc. (ISRG) Investor Outlook: A 16.08% Potential Upside Awaits

Intuitive Surgical, Inc. (NASDAQ: ISRG), a leader in the healthcare sector, continues to capture investor attention with its cutting-edge innovations in the field of minimally invasive medical technology. With a..

Mettler-Toledo International Inc. (MTD) Stock Analysis: A Precision Leader with a 6.95% Upside Potential

Mettler-Toledo International Inc. (NYSE: MTD) stands as a significant player in the healthcare sector, specializing in diagnostics and research. With a market capitalization of $28.97 billion, this Ohio-based company has..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: Understanding the Potential 11% Upside

Teva Pharmaceutical Industries (NYSE: TEVA), a major player in the healthcare sector, has piqued investor interest with its promising 11.03% potential upside, according to recent analyst ratings. This Israel-based company,..

Centene Corporation (CNC) Stock Analysis: Navigating the Healthcare Plan Giant Amidst a Dynamic Market

Centene Corporation (NYSE: CNC) stands out as a significant player in the healthcare sector, focusing on providing essential services to under-insured and uninsured families across the United States. With a..

Zoetis Inc. (ZTS) Stock Analysis: Exploring a 24.77% Potential Upside Amid Strong Buy Ratings

Zoetis Inc. (NYSE: ZTS), a leader in the animal health industry, is capturing investor attention with a promising 24.77% potential upside according to recent analyst ratings. As a key player..

Insmed Incorporated (INSM) Stock Analysis: Potential 37% Upside Amid Robust Revenue Growth

Investors are closely eyeing Insmed Incorporated (NASDAQ: INSM) as this biotechnology company continues to make strides in developing therapies for serious and rare diseases. With a market capitalization of $33.32..

Koninklijke Philips N.V. (PHG) Stock Analysis: Exploring a 10.61% Potential Upside Amidst Strategic Healthcare Innovations

Investors eyeing the healthcare sector may find Koninklijke Philips N.V. (NYSE: PHG) an intriguing option, particularly with its potential upside of 10.61% based on current analyst targets. As a cornerstone..

Fresenius Medical Care AG (FMS) Investor Outlook: A 30% Upside Potential Amidst Industry Challenges

Fresenius Medical Care AG (FMS), a prominent player in the healthcare sector, is at the forefront of medical care facilities, specializing in dialysis and related services. As it navigates the..

ResMed Inc. (RMD) Stock Analysis: Unraveling a 15.83% Potential Upside in Healthcare Innovation

ResMed Inc. (NYSE: RMD), a prominent player in the healthcare sector, particularly in the medical instruments and supplies industry, presents a compelling opportunity for investors. With a robust market capitalization..

Natera, Inc. (NTRA) Stock Analysis: Exploring a 6.47% Potential Upside Amid Strong Revenue Growth

Natera, Inc. (NASDAQ: NTRA), a leader in the diagnostics and research industry, has been making waves in the healthcare sector with its advanced molecular testing services. With a market cap..

Johnson & Johnson (JNJ) Stock Analysis: A Healthcare Giant with a Promising 1.79% Potential Upside

Johnson & Johnson (NYSE: JNJ), a stalwart in the healthcare sector, continues to capture investor interest, combining a robust market presence with steady growth potential. With a towering market capitalization..

Biogen Inc. (BIIB) Stock Analysis: A Closer Look at Its 11.98% Potential Upside

Biogen Inc. (BIIB), a prominent player in the healthcare sector, particularly within the drug manufacturing industry, has drawn investor interest with its expansive portfolio of therapies targeting neurological and neurodegenerative..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: Exploring a 9.34% Potential Upside in the Healthcare Sector

Smith & Nephew SNATS, Inc. (NYSE: SNN), a stalwart in the medical devices industry, presents an intriguing opportunity for investors seeking exposure to the healthcare sector. The London-based company, with..

Merck & Co. (MRK) Stock Analysis: Exploring Growth Potential and Strong Analyst Sentiment

Merck & Company, Inc. (NYSE: MRK), a global leader in the healthcare sector, continues to capture investor attention thanks to its robust pipeline, strategic partnerships, and favorable analyst ratings. With..

Insulet Corporation (PODD) Stock Analysis: 37.68% Potential Upside Amid Strong Revenue Growth

Insulet Corporation (NASDAQ: PODD), a prominent player in the healthcare sector, particularly in medical devices, is making waves with its innovative insulin delivery systems. With a substantial market capitalization of..

Encompass Health Corporation (EHC) Stock Analysis: Exploring a 42% Upside Potential with Robust Analyst Ratings

Encompass Health Corporation (NYSE: EHC) stands out in the healthcare sector with its specialized focus on post-acute healthcare services. Based out of Birmingham, Alabama, Encompass Health operates extensive inpatient rehabilitation..

Illumina, Inc. (ILMN) Stock Analysis: Navigating Valuation Challenges Amidst Growth Opportunities

Illumina, Inc. (NASDAQ: ILMN), a pivotal player in the diagnostics and research industry, continues to command attention from investors due to its cutting-edge genetic and genomic analysis solutions. As a..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds